Anavex Life Sciences Corp.
TREATMENT OF CARDIAC DYSFUNCTION

Last updated:

Abstract:

A method for treatment of cardiac dysfunction comprising administering to a subject in need thereof a therapeutically effective amount of at least one of ANAVEX 2-73 or ANAVEX 19-144 or a pharmaceutically acceptable salt thereof or a combination thereof.

Status:
Application
Type:

Utility

Filling date:

26 Jul 2021

Issue date:

31 Mar 2022